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Tobias Gedde-Dahl Jr. (1934–2006)
Tobias Gedde-Dahl Jr., one of the pioneers of international 
research on epidermolysis bullosa, died on March 2, 2006, in 
Oslo, Norway, after a short illness. Tobias grew up in the vicin-
ity of Oslo and studied medicine at the University there. After 
earning an MD in 1958, he worked from 1961 to 1968 at the 
Institute of Medical Genetics and thereafter for one-and-a-
half years in the Department of Dermatology at the National 
Hospital, Oslo. It was during this period that he started his 
research on the genetics of epidermolysis bullosa (EB), and in 
1970 he defended his academic thesis entitled “Epidermolysis 
bullosa: a clinical, genetic and epidemiological study.” The 
genetics of EB and other heritable skin diseases remained his 
primary research focus during his entire career, first as a sen-
ior researcher in the Department of Genetics at the Norwegian 
Radium Hospital (1970–1986), then as professor and chair 
of the Department of Medical Genetics at the University of 
Tromsø/University Hospital of Tromsø (1986–1990), and subse-
quently as a senior researcher and chief of the Dermatological 
DNA Laboratory at the National Hospital in Oslo (1992–2004).
Tobias was very devoted to his patients and to his research 
on EB genetics. When he traveled from Tromsø in the far north 
of Norway to visit his family in Oslo, some 2,000 kilometers 
to the south, the technical staff at the Genetics Department in 
Tromsø knew they could expect a lot of work. Instead of tak-
ing the shortest route, he always detoured from the main road 
to visit the often small and isolated places where his patients 
lived, to talk with them, and to obtain blood samples and skin 
biopsies for his research. One of us (J.-O.W.) also remembers a 
trip with Tobias to a dermatology meeting in Gleneden Beach, 
Oregon, in 1985. During the six-hour wait between planes 
at Kennedy Airport, Tobias had arranged to meet with family 
members of Norwegian EB patients living in the New York area 
to obtain blood samples and skin biopsies. One of his mile-
stones, one he was particularly proud of, was the founding 
of the patient organization DebRA Norway in 1991, together 
with affected individuals and their families. He even managed 
to obtain governmental support for this patient organization.
Tobias’s contribution to EB research started with his early 
diagnostic and genetic investigations that led to the classifi-
cation of new EB types. His main research tool was genetic 
linkage analysis, and using this method he traced the inheri-
tance of EB in Scandinavian families. This was combined with 
his interest in genealogy: he traced EB mutations back to the 
sixteenth century in some families and used this knowledge 
to investigate how Norwegian, Scandinavian, and European 
populations had moved during history. His devotion to 
research is best reflected by his large scientific contribution, 
with over 150 papers in scientific journals, several book 
chapters, and several hundred meeting abstracts. Tobias was 
often invited to chair sessions in (dermato)genetics meet-
ings, and, perhaps unexpectedly, a significant number of his 
observations were reported in meeting abstracts instead of 
full scientific papers.
The work of Tobias Gedde-Dahl Jr. laid a solid founda-
tion to later molecular investigations, genetic and biologi-
cal, by many scientists all over the world. On the basis of 
his findings, and in collaboration with him, they studied EB, 
disclosed causative genes for the different EB subtypes, iden-
tified pathogenetic pathways leading from the mutation to 
skin blistering, and, finally, laid a basis for biologically valid 
therapeutic approaches.
Tobias will be missed not only by his family and collabora-
tion partners, but also by all the EB patients and their families 
with whom he always had close contact. His death is also a 
big loss for the genetic and dermatological scientific commu-
nity to which he contributed so much.
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